相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ORCA study: real-world versus reading centre assessment of disease activity of neovascular age-related macular degeneration (nAMD)
Sandra Liakopoulos et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2020)
Association of Visit Adherence and Visual Acuity in Patients With Neovascular Age-Related Macular Degeneration Secondary Analysis of the Comparison of Age-Related Macular Degeneration Treatment Trial
Meera S. Ramakrishnan et al.
JAMA OPHTHALMOLOGY (2020)
Safety and Efficacy of Anti-Vascular Endothelial Growth Factor Therapies for Neovascular Age-Related Macular Degeneration A Report by the American Academy of Ophthalmology
Sophie J. Bakri et al.
OPHTHALMOLOGY (2019)
Lack of Treatment Persistence and Treatment Nonadherence as Barriers to Glycaemic Control in Patients with Type 2 Diabetes
Bruno Guerci et al.
DIABETES THERAPY (2019)
Treatment compliance and adherence among patients with diabetic retinopathy and age-related macular degeneration treated by anti-vascular endothelial growth factor under universal health coverage
Reinhard Angermann et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2019)
Exploring factors predicting changes in patients' expectations and psychosocial issues during the course of treatment with intravitreal injections for wet age-related macular degeneration
S. Sii et al.
EYE (2018)
Risk Factors for Discontinuation of Treatment for Neovascular Age-Related Macular Degeneration
Inger Westborg et al.
OPHTHALMIC EPIDEMIOLOGY (2018)
Reasons for delayed and discontinued therapy in age-related macular degeneration
M. W. M. Wintergerst et al.
OPHTHALMOLOGE (2018)
Experiences of patients undergoing repeated intravitreal anti-vascular endothelial growth factor injections for neovascular age-related macular degeneration
Jessica Boyle et al.
PSYCHOLOGY HEALTH & MEDICINE (2018)
TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION PATIENTS WITH VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITORS IN EVERYDAY PRACTICE Identification of Health Care Constraints in Germany-The PONS Study
Christoph Ehlken et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2018)
Age-related macular degeneration
Paul Mitchell et al.
LANCET (2018)
Loss to Follow-up Among Patients With Neovascular Age-Related Macular Degeneration Who Received Intravitreal Anti-Vascular Endothelial Growth Factor Injections
Anthony Obeid et al.
JAMA OPHTHALMOLOGY (2018)
Real-world visual outcomes in patients with neovascular age-related macular degeneration receiving aflibercept at fixed intervals as per UK licence
Mehmet Ozturk et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2018)
Association of treatment adherence with real-life VA outcomes in AMD, DME, and BRVO patients
Christoph Ehlken et al.
CLINICAL OPHTHALMOLOGY (2018)
The burden of neovascular age-related macular degeneration: a patient's perspective
Kimberly L. Spooner et al.
CLINICAL OPHTHALMOLOGY (2018)
Neovascular age-related macular degeneration treated with ranibizumab or aflibercept in the same large clinical setting: visual outcome and number of injections
Annette Rasmussen et al.
ACTA OPHTHALMOLOGICA (2017)
A fast track to improve management of neovascular age related macular degeneration
V. Krivosic et al.
JOURNAL FRANCAIS D OPHTALMOLOGIE (2017)
NATURAL COURSE OF PATIENTS DISCONTINUING TREATMENT FOR AGE-RELATED MACULAR DEGENERATION AND FACTORS ASSOCIATED WITH VISUAL PROGNOSIS
Jae Hui Kim et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2017)
The impact of different anti-vascular endothelial growth factor treatment regimens on reducing burden for caregivers and patients with wet age-related macular degeneration in a single-center real-world Japanese setting
Tsukasa Hanemoto et al.
PLOS ONE (2017)
Factors Affecting Compliance to Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Patients with Age-Related Macular Degeneration
Onur Polar et al.
TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY (2017)
Psychological impact of anti-VEGF treatments for wet macular degeneration-a review
Hugo Senra et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2016)
Compliance of age related macular degeneration patients undergoing anti-VEGF therapy. Analysis and suggestions for improvement
B. Heimes et al.
OPHTHALMOLOGE (2016)
METAANALYSIS OF REAL-WORLD OUTCOMES OF INTRAVITREAL RANIBIZUMAB FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Leah N. Kim et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2016)
Physician, patient, and caregiver experience of different wet age-related macular degeneration anti-VEGF treatment regimens in Japan: a qualitative assessment
Tomohiro Iida et al.
CLINICAL OPHTHALMOLOGY (2016)
Evaluating the impact of summer vacation on the visual acuity of AMD patients treated with ranibizumab
N. Massamba et al.
EYE (2015)
Ranibizumab for exudative age-related macular degeneration: A five year study of adherence to follow-up in a real-life setting
E. Boulanger-Scemama et al.
JOURNAL FRANCAIS D OPHTALMOLOGIE (2015)
Long-Term Outcomes of Treatment of Neovascular Age-Related Macular Degeneration Data from an Observational Study
Mark C. Gillies et al.
OPHTHALMOLOGY (2015)
Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration
Frank G. Holz et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2015)
Experiences of patients undergoing anti-VEGF treatment for neovascular age-related macular degeneration: A systematic review
Jessica Boyle et al.
PSYCHOLOGY HEALTH & MEDICINE (2015)
Current barriers to treatment for wet age-related macular degeneration (wAMD): findings from the wAMD patient and caregiver survey
Monica Varano et al.
CLINICAL OPHTHALMOLOGY (2015)
Anti-VEGF Treatment Patterns for Neovascular Age-Related Macular Degeneration Among Medicare Beneficiaries
Eleonora M. Lad et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2014)
Patient preference of ranibizumab treatment regimen for neovascular age-related macular degeneration - monthly injections versus pro re nata
Katharina M. Droege et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2014)
REASONS FOR DISCONTINUATION OF INTRAVITREAL VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITORS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Anagha Vaze et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2014)
Four-Year Treatment Results of Neovascular Age-Related Macular Degeneration With Ranibizumab and Causes for Discontinuation of Treatment
Mads Kruger Falk et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2013)
Adherence to ranibizumab treatment for neovascular age-related macular degeneration in real life
Katharina M. Droege et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2013)
Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON
Soraya Rofagha et al.
OPHTHALMOLOGY (2013)
Adherence to Therapies in Patients with Type 2 Diabetes
Luis-Emilio Garcia-Perez et al.
DIABETES THERAPY (2013)
Treatment Patterns for Neovascular Age-Related Macular Degeneration: Analysis of 284 380 Medicare Beneficiaries
Lesley H. Curtis et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2012)
Age-related macular degeneration
Laurence S. Lim et al.
LANCET (2012)
Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
Jeffrey S. Heier et al.
OPHTHALMOLOGY (2012)
Remission and dropout rate of anti-VEGF therapy for age-related macular degeneration
Akio Oishi et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2011)
Causes of interruption of bevacizumab therapy in age-related macular degeneration
Renata Portella Nunes et al.
ARQUIVOS BRASILEIROS DE OFTALMOLOGIA (2010)
A Clinician's Guide to the Assessment and Management of Nonadherence in Glaucoma
Donald L. Budenz
OPHTHALMOLOGY (2009)
Patient-Centered Communication to Assess and Enhance Patient Adherence to Glaucoma Medication
Steven R. Hahn
OPHTHALMOLOGY (2009)
Ranibizumab versus verteporfin for neovascular age-related macular degeneration
David M. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
分享论文
